Efficacy of the Indigo mechanical thrombectomy for the acute deep venous thrombosis of lower extremity
Journal Title: Chinese Journal of Clinical Research - Year 2025, Vol 38, Issue 2
Abstract
Objective：To compare the efficacy of Indigo mechanical thrombectomy and catheter-directed thrombolysis (CDT) in the treatment of acute deep vein thrombosis (DVT) of the lower extremity. Methods： A retrospective analysis was conducted on the clinical data of 108 patients with acute lower extremity DVT treated at Xuzhou Central Hospital from December 2022 to December 2023. According to the treatment method, patients were divided into two groups. The control group consisted of 57 patients who received CDT treatment, while the experimental group consisted of 51 patients who underwent Indigo mechanical thrombectomy. Postoperative venous patency scores, postoperative venous patency rates, swelling reduction rates of the affected limbs, thrombus clearance grades, dosages of urokinase, thrombolytic times, and hospital stays were compared between the two groups.Results： The postoperative venous patency score in the experimental group was lower than that in the control group (1.63±1.00 vs 2.35±1.08), while the venous patency rate ［(78.97±13.04)% vs (68.07±14.25)%］ and the swelling reduction rate ［(72.31±11.70)% vs (65.68±8.27)%］ were higher in the experimental group compared to the control group, with statistically significant differences (P＜0.05). The dosage of urokinase in the experimental group ［(146.08±35.85)×10000 units vs (308.42±45.33)×10000 units］ was lower than in the control group, and the thrombolysis time ［(2.39±0.78)days vs (5.11±0.82)days］ and hospital stays ［(8.37±0.96) days vs (10.37±1.10) days］ were shorter in the experimental group, with statistically significant differences (P＜0.05). No significant difference was observed between the two groups in terms of thrombus clearance grading (P＞0.05). Follow-up time ranged from 6 to 18 months, and all patients with implanted stents had patent stents without any occurrence of stenosis or occlusion. Conclusion： Compared to CDT, the Indigo mechanical thrombectomy treatment regimen has more significant advantages, including reducing the use of thrombolytic drugs, shortening treatment time, improving thrombolytic effects, and being easy to operate.
Authors and Affiliations
TIAN Zhong, TIAN Zhilong, SUN Pengcheng, QIN Ruihao, YUAN Fukang
Keywords
Related Articles
- EP ID EP759944
- DOI 10.13429/j.cnki.cjcr.2025.02.012
- Views 31
- Downloads 0
Establishment and validation of a prediction model for death during hospitalization in elderly patients with sepsis combined with acute kidney injury
Objective To initially establish a prediction model for death during hospitalization in elderly patients with sepsis combined with acute kidney injury (AKI) and validate it. Methods Clinical data of 378 elderly patient...
Comparison of remimazolam versus propofol in combination with remifentanil in hysteroscopic surgery
"<b>Objective</b> To compare the anesthesia effect and hemodynamics of remimazolam versus propofol in combination with remifentanil in hysteroscopic surgery. <b>Methods</b> A total of 60 patients who underwent electi...
Research progress of fibroblast growth factor receptor in gastric cancer
The incidence and mortality of gastric cancer are in the forefront of the tumor, and the prognosis is poor, especially in the middle and advanced stage. Even with comprehensive treatment, the 5- year survival is very lo...
Risk factors associated with severe coronavirus disease 2019 in maintenance hemodialysis patients
<b>Objective</b> To analyze the risk factors of severe coronavirus disease 2019 (COVID-19) in maintenance hemodialysis patients, and provide reference for early risk identification of the patients. <b>Methods</b> The...
Expression levels and clinical significance of NLRP3 and HMGB1 derived from platelets in patients with gout
"<b>Objective</b> To investigate the expression levels of NOD-like receptor family pyrin domain-containing 3 (NLRP3) and high mobility group box-1 proten (HMGB1) in platelets derived from patients with gout, as well as t...